Virpax Pharmaceuticals, Inc. (VRPX) Financials
VRPX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 13.0 million | 6.5 million |
| June 30, 2023 | 16.0 million | 3.6 million |
| March 31, 2023 | 18.5 million | 3.3 million |
| Dec. 31, 2022 | 19.7 million | 3.1 million |
VRPX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -2.7 million | 195564 |
| June 30, 2023 | -2.2 million | 218257 |
| March 31, 2023 | -2.0 million | 140583 |
| Dec. 31, 2022 | -1.6 million | 138276 |
VRPX Net Income
No data available :(
VRPX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 12.2 million | - | - |
| June 30, 2023 | 14.8 million | - | - |
| March 31, 2023 | 17.0 million | - | - |
| Dec. 31, 2022 | 19.0 million | - | - |
VRPX Shares Outstanding
VRPX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 1.5 million | 4.6 million | - |
| June 30, 2023 | - | 1.3 million | 1.9 million | - |
| March 31, 2023 | - | 1.2 million | 415451 | - |
| Dec. 31, 2022 | - | 1.4 million | 1.7 million | - |
VRPX Cost of Revenue
No data available :(
VRPX
Price: $0.01
52 week price:
Earnings Per Share: -71.00 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123600
Market Capitalization: 497